Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-Associated cancer

BMJ Open Gastroenterology

Volumn 2, Issue 1, 2015, Pages

  Corfe, Bernard M ^a,b   Majumdar, Debabrata ^a,c   Assadsangabi, Arash ^a,c   Marsh, Alexandra M R ^a,c   Cross, Simon S ^b   Connolly, Joanne B ^d   Evans, Caroline A ^b   Lobo, Alan J ^a,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d WATERS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; KERATIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; GASTROINTESTINAL DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; PANCOLITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; RECTUM MUCOSA; ULCERATIVE COLITIS;

EID: 85019424343     PISSN: None     EISSN: 20544774     Source Type: Journal    
DOI: 10.1136/bmjgast-2014-000024     Document Type: Article

References (41)

1. Omary MB, Ku NO, Liao J, et al. Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell Biochem 1998;31:105-40.
2. Majumdar D, Tiernan JP, Lobo AJ, et al. Keratins in colorectal epithelial function and disease. Int J Exp Pathol 2012;93:305-18.
3. Osborn M. Intermediate filaments as histologic markers: An overview. J Invest Dermatol 1983;81(1 Suppl):104s-109s.
4. Leech SH, Evans CA, Shaw L, et al. Proteomic analyses of intermediate filaments reveals cytokeratin8 is highly acetylated-implications for colorectal epithelial homeostasis. Proteomics 2008;8:279-88.
5. Ku NO, Azhar S, Omary MB. Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation. J Biol Chem 2002;277:10775-82.
6. Liao J, Ku NO, Omary MB. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J Biol Chem 1997;272:17565-73.
7. He T, Stepulak A, Holmstrom TH, et al. The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-Terminal kinase. J Biol Chem 2002;277:10767-74.
8. Snider NT, Weerasinghe SVW, Iniguez-Lluhi JA, et al. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation. J Biol Chem 2011;286:2273-84.
9. Omary MB, Ku NO, Tao GZ, et al. Heads and tails of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem Sci 2006;31:383-94.
10. Coulombe PA, Omary MB. Hard and soft principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 2002;14:110-22.
11. Caulin C, Ware CF, Magin TM, et al. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J Cell Biol 2000;149:17-22.
12. Gilbert S, Loranger A, Daigle N, et al. Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-Targeting modulation. J Cell Biol 2001;154:763-73.
13. Ngan CY, Yamamoto H, Seshimo I, et al. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer 2007;96:986-92.
14. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34.
15. Dignass AU, Baumgart DC, Sturm A. Review article: The aetiopathogenesis of inflammatory bowel disease-immunology and repair mechanisms. Aliment Pharmacol Ther 2004;20 (Suppl 4):9-17.
16. Owens DW, Lane EB. Keratin mutations and intestinal pathology. J Pathol 2004;204:377-85.
17. Owens DW, Wilson NJ, Hill AJ, et al. Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients. J Cell Sci 2004;117(Pt 10):1989-99.
18. Baribault H, Penner J, Iozzo RV, et al. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994;8:2964-73.
19. Habtezion A, Toivola DM, Butcher EC, et al. Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment. J Cell Sci 2005;118(Pt 9):1971-80.
20. Habtezion A, Toivola DM, Asghar MN, et al. Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon. Proc Natl Acad Sci USA 2011;108:1445-50.
21. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-Analysis. GUT 2001;48:526-35.
22. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228-33.
23. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-Analysis. Gastrointest Endosc 2002;56:48-54.
24. Cooper HS, Murthy S, Kido K, et al. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-Associated neoplasia in the human: A study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000;21:757-68.
25. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9.
26. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study. Gastroenterology 2007;133:1099-105; quiz 340-1.
27. Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004;3:1154-69.
28. May D, Pan S, Crispin DA, et al. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. J Proteome Res 2011;10:200-9.
29. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-Aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-9.
30. Majumdar D, Rosser R, Havard S, et al. An integrated workflow for extraction and solubilization of intermediate filaments from colorectal biopsies for proteomic analysis. Electrophoresis 2012;33:1967-74.
31. Pham TK, Roy S, Noirel J, et al. A quantitative proteomic analysis of biofilm adaptation by the periodontal pathogen Tannerella forsythia. Proteomics 2010;10:3130-41.
32. Li GZ, Vissers JPC, Silva JC, et al. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009;9:1696-719.
33. Drake PJ, Griffiths GJ, Shaw L, et al. Application of high-content analysis to the study of post-Translational modifications of the cytoskeleton. J Proteome Res 2009;8:28-34.
34. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
35. Khan AQ, Bury JP, Brown SR, et al. Keratin 8 expression in colon cancer associates with low faecal butyrate levels. BMC Gastroenterol 2011;11:2.
36. Mizuuchi E, Semba S, Kodama Y, et al. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Int J Cancer 2009;124:1802-10.
37. Rodriguez-Suarez E, Whetton AD. The application of quantification techniques in proteomics for biomedical research. Mass Spectrom Rev 2013;32:1-26.
38. Toivola DM, Krishnan S, Binder HJ, et al. Keratins modulate colonocyte electrolyte transport via protein mistargeting. J Cell Biol 2004;164:911-21.
39. Treton X, Pedruzzi E, Cazals-Hatem D, et al. Altered endoplasmic reticulum stress affects translation in inactive colon tissue from patients with ulcerative colitis. Gastroenterology 2011;141:1024-35.
40. Mitsuhashi J, Mikami T, Saigenji K, et al. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21(WAF1) expression in rectal mucosa and neoplastic development. Pathol Int 2005;55:113-21.
41. Okayasu I, Yoshida T, Mikami T, et al. Mucosal remodeling in long-standing ulcerative colitis with colorectal neoplasia: significant alterations of NCAM plus or alpha-SMA plus subepithelial myofibroblasts and interstitial cells. Pathol Int 2009;59:701-11.